<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Melanoma Research Foundation | Mark | Mentions</title>
	<link>https://forum.melanoma.org/user/mark/activity/mentions/</link>
	<atom:link href="https://forum.melanoma.org/user/mark/activity/mentions/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed mentioning Mark.</description>
	<lastBuildDate>Tue, 21 Apr 2026 23:43:43 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">767bde4cec352453eb815c3e86e453a5</guid>
				<title>AZSoCal replied to the topic Question about pathology reports in the forum General Melanoma Community</title>
				<link>https://forum.melanoma.org/forums/topic/question-about-pathology-reports/#post-277214</link>
				<pubDate>Thu, 08 Sep 2022 23:49:05 -0400</pubDate>

									<content:encoded><![CDATA[<p><a href='https://forum.melanoma.org/user/ed/' rel="nofollow ugc">@Ed</a>,<br />
Thank you! Super helpful context. I was with UCLA originally before transitioning to another center. I was not under Dr Ribas&#8217; care but I had heard good things. </p>
<p><a href='https://forum.melanoma.org/user/mark/' rel="nofollow ugc">@Mark</a>,<br />
Thank you as well, and glad to hear you found success in this treatment path. I&#8217;m generally encourage that TVEC probably had some positive effect, and while I&#8217;ll never truly&hellip;<span class="activity-read-more" id="activity-read-more-28239"><a href="https://forum.melanoma.org/forums/topic/question-about-pathology-reports/#post-277214" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
		
	</channel>
</rss>